Clinical and dietary determinants of muscle mass in patients with type 2 diabetes: Data from the diabetes and lifestyle cohort twente

Autor: Stephan J. L. Bakker, Ilse J. M. Hagedoorn, Annis C Jalving, Gozewijn D. Laverman, Gerjan Navis, Milou M. Oosterwijk

Publikováno v: Journal of Clinical Medicine, 10(22):5227. MDPI AG
Journal of Clinical Medicine
Volume 10
Issue 22
Journal of Clinical Medicine, Vol 10, Iss 5227, p 5227 (2021)
Journal of Clinical Medicine, 10(22):5227. Multidisciplinary Digital Publishing Institute (MDPI)

Low muscle mass in patients with type 2 diabetes is associated with a progressively higher risk of morbidity and mortality. The aim of this study was to identify modifiable targets for intervention of muscle mass in type 2 diabetes. Cross-sectional a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1a127f21d02b5cd6b5ab6cc8e026cb8
https://research.rug.nl/en/publications/4b3c6ad9-dead-4c0b-8b67-31aecd9b6f84

Low Physical Activity in Patients with Complicated Type 2 Diabetes Mellitus Is Associated with Low Muscle Mass and Low Protein Intake

Autor: Ilse J. M. Hagedoorn, Gozewijn D. Laverman, Niala den Braber, Cristina M. Gant, Milou M. Oosterwijk, Gerjan Navis, Miriam Marie Rosé Vollenbroek-Hutten, Stephan J. L. Bakker, Bert-Jan van Beijnum

Publikováno v: Journal of Clinical Medicine, 9(10):3104. MDPI AG
Journal of Clinical Medicine
Volume 9
Issue 10
Journal of Clinical Medicine, Vol 9, Iss 3104, p 3104 (2020)
Journal of Clinical Medicine, 9(10):3104. MDPI

Objective: In order to promote physical activity (PA) in patients with complicated type 2 diabetes, a better understanding of daily movement is required. We (1) objectively assessed PA in patients with type 2 diabetes, and (2) studied the association

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::570a8a5e1637a4431a772f79c2684965
https://research.rug.nl/en/publications/a35ba6a9-bb34-43a9-ad90-082aeb1f5301

Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

Autor: Verusca Lecchi, Pamela Surtees, Jessie A. Hermann, Marina Noutsou, Lidmila Francová, Francesca Lo Bue, Silvia Prandini, Annika Durban, Heidrun Wölk, Suzy van Steenderen, Gemma Currie, Rüdiger Göke, Ivan Rychlik, Daniela Cugini, Annette Busmann, Ulrike Wittkop, Svitlana Yakymchuk, John R. Petrie, Slavica S. Stratrova, Stanley M H Yeung, Julia Raad, Antonio Cannata, Ninna Hahn Tougaard, Robbie Wilson, Barbara Neuhaus, Joachim Beige, Olivera Stojceva-Taneva, Harald Mischak, Tine W. Hansen, Giulia Gherardi, Caroline Boukens-de Graaf, Renata Amanaki, Francesco Nones, Anneke K. De Bruin, Aneliya Parvanova, Elizabeth Douglas, Carolina Aparicio, Gerjan Navis, Tereza Havrdova, Alberto Ortiz, Maria Dolores Sanchez-Niño, Simone Theilade, Ferrina Clerc-de Jong, Signe Abitz Winther, Adrian M. Ramos, Regina Ax-Smolarski, Ingo Dimos, Christina M. Gant, Peter Girman, Friedrich W. Petry, Peter Rossing, Bruno Lapauw, Katarina Adamova, Rikke J. Stefansen, Michael Prigge, Mie K. Eickhoff, Petra Zürbig, Viktor Rotbain Curovic, Davide Villa, Goce Spasovski, Marian Nannings, Adriaan Kooy, Joanne Flynn, Therese Frost Lerche, Veit Zieglschmid, Flavio Gaspari, Gjulsen Selim, Marijn M. Speeckaert, Jens C. Laursen, Elsie de Man, Signe Rosenlund, Christian Delles, Giel Nijpels, Katriona Brooksbank, Alessandro Villa, Ilian Iliev, Morten Lindhardt, Maria A. Campbell, Lone Jelstrup, Gozewijn D. Laverman, Matias Trillini, Ulrike Schmidt, Kristin Kreutzmann, Silke Zimmermann, Ceyda Kilic, Tina R. Juhl, Silvia Ferrari, Nadia Stucchi, Beatriz Fernandez-Fernandez, Christian Stevns Hansen, Femke Rutters, Brenda Wierbos, Sabien Inion, Maria Lajer, Justyna Siwy, Jannet Entius, Sascha Pilemann-Lyberg, Lene Aabo, Heiko von der Leyen, Elina Eldeik, Tatjana Gjorgovski, Marie Frimodt-Møller, Isabelle Dewettinck, Maja L.D. Halkjær, Joline W.J. Beulens, Šárka Albrechtová, Stephan J. L. Bakker, Hiddo J.L. Heerspink, Brit Rädisch, Clotilde Vázquez, Ilse J. M. Hagedoorn, Dorthe Riis, Bernt Johan von Scholten, Andreas L. Birkenfeld, Kelly Rokegem, Ana Belen Sanz, Frederik Persson, Eva Bollweber, Anika Hävemeier, Frank Huvers, Petra Schutten-Westerneng, Piero Ruggenenti, Sharon Kean, Maria Á. Gonzalo, Anne G. Lundgaard, Marco Schiemann, Emilie H. Zobel, Nete Tofte, Joe Galloway, Daniela Melacini, Jinny Sanchez-Rodriguez

Publikováno v: Lancet Diabetes & Endocrinology, 8(4), 301-312. ELSEVIER SCIENCE INC
Tofte, N, Lindhardt, M, Adamova, K, Bakker, S J L, Beige, J, Beulens, J W J, Birkenfeld, A L, Currie, G, Dimos, I, Francová, L, Frimodt-Møller, M, Girman, P, Göke, R, Havrdova, T, Heerspink, H J L, Kooy, A, Laverman, G D, Mischak, H, Navis, G, Nijpels, G, Noutsou, M, Ortiz, A, Parvanova, A, Persson, F, Petrie, J R, Ruggenenti, P L, Rutters, F, Rychlík, I, Siwy, J, Spasovski, G, Speeckaert, M, Trillini, M, Zürbig, P, von der Leyen, H, Rossing, P, PRIORITY investigators & Nijpels, MGAAM 2020, ' Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY) : a prospective observational study and embedded randomised placebo-controlled trial ', The Lancet Diabetes and Endocrinology, vol. 8, no. 4, pp. 301-312 . https://doi.org/10.1016/S2213-8587(20)30026-7
Ann Transl Med
The Lancet Diabetes and Endocrinology, 8(4), 301-312. Elsevier BV
Lancet Diabet. Endocrinol. 8, 301-312 (2020)

Background: \ud Microalbuminuria is an early sign of kidney disease in people with diabetes and indicates increased risk of cardiovascular disease. We tested whether a urinary proteomic risk classifier (CKD273) score was associated with development o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c330f7cf6c46dc4a204c768eaea4bed
https://eprints.gla.ac.uk/212534/13/212534.pdf

Clinical and Dietary Determinants of Muscle Mass in Patients with Type 2 Diabetes: Data from the Diabetes and Lifestyle Cohort Twente.

Autor: Jalving, Annis C.¹ (AUTHOR) annis-jalving@hotmail.com, Oosterwijk, Milou M.¹ (AUTHOR) ilse_hagedoorn10@hotmail.com, Hagedoorn, Ilse J. M.¹ (AUTHOR) g.laverman@zgt.nl, Navis, Gerjan² (AUTHOR) g.j.navis@umcg.nl, Bakker, Stephan J. L.² (AUTHOR) s.j.l.bakker@umcg.nl, Laverman, Gozewijn D.^1,3 (AUTHOR)

Publikováno v: Journal of Clinical Medicine. Nov2021, Vol. 10 Issue 22, p5227-5227. 1p.

Requirements of an Application to Monitor Diet, Physical Activity and Glucose Values in Patients with Type 2 Diabetes: The Diameter.

Autor: den Braber, Niala, Vollenbroek-Hutten, Miriam M. R., Oosterwijk, Milou M., Gant, Christina M., Hagedoorn, Ilse J. M., van Beijnum, Bert-Jan F., Hermens, Hermie J., Laverman, Gozewijn D.

Publikováno v: Nutrients; Feb2019, Vol. 11 Issue 2, p409, 1p